Endocrinology AS Flashcards
Diabetes Mellitus definition
Multisystem disorder due to an absolute or relative lack of endogenous insulin –> Metabolic and vascular complications
Type 1 DM
T1DM
- Pathology: autoimmune destruction of B-cells –> absolute insulin deficiency
- Age: usually starts before puberty
- Presentation: Polyuria, polydipsia, decreased weight, DKA.
- Genetics: concordance only 30% in MZ
- Association: HLA-D3 and D4, other AI disease
- Abs: Anti-islet, anti-GAD
T2DM?
Pathology: Insulin resistance and B-cell dysfunction –> relative insulin deficiency
Age: Usually older patients
Presentation: polyuria, polydipsia, complications
Genetics: concordance 80% in MZs
Associated: Obesity, decreased exercise, calorie and ETOH excess
Diagnosis of symptomatic diabetes?
Symptomatic - Polyuria, polydipsia, decreased weight, lethargy.
Need 1 test
- Increased plasma venous glucose detected once!
- Fasting >7mm
- Random >11.1
- 2 hr Plasma glucose >11.1 2hr after ingestion of glucose during OGTT (need to check with blood)
- HbA1c >48 mmol/ >6.5
Beware that sickle cell anaemia and other haemoglobinopathies can give falsely low HbA1c readings due to decreased lifespan of RBCs.
Sickle cell, G6PD, hereditary is low.
Vit B12, folic acid and iron deficiency anaemia, splenectomy give higher readings due to higher red blood cell lifespan.
Consider measuring C-peptide after initial presentation if there is difficuly distinguishing type 1 from others. C-peptide is low in T1DM. Normal or high in Type 2
Diagnosis of Asymptomatic diabetes?
in an asymptomatic person, the diagnosis of diabetes should never be based on a single abnormal HbA1c or fasting plasma glucose level; at least one additional abnormal HbA1c or plasma glucose level is essential. If the second test results are normal, it is prudent to arrange regular review of the person.
- Increased venous glucose on 2 separate occasions.
- Or 2h OGTT >11.1 mM
- 2 Separate HbA1c readings.
What is a OGTT?
- Only needed if borderline fasting or random glucose measurements
What is normal fasting glucose?
<6.1 (<41)
What is impaired fasting glucose defined as?
- 1-6.9 fasting (42-47)
- These patients should be recommended diet and exercise.
What is diabetes defined as on fasting glucose?
> 7 (>48)
What is normal in a 75g OGTT?
<7.8
What is impaired glucose tolerance
7.8-11
What is diabetes on OGTT?
> 11.1
What are secondary drug causes of DM?
Drugs: Steroids, anti-HIV, atypical neuroleptics, thiazides
what are secondary pancreatic causes of DM?
CF, chronic pancreatitis, HH, pancreatic Ca
What are secondary endo causes of DM?
Phaeo, Cushings (increases blood sugar), Acromegaly, hyperthyroidism
Other: glycogen storage
What is metabolic syndrome?
- Central obesity (increased weight circumference >102 in men, 88 women
- Triglycerides 150mg/dl
- HDL-cholesterol <40mg/dL in men and <50 mg/dl in women
- HTN: BP 130/85
- DM, IGT, IFG
Conservative management of diabetes?
- MDT
GP, endorinologist, surgeons, specialist nurses, dieticians, chiropodists, fellow patients (education groups)
The 4Cs of diabetes monitoring?
Control - glycaemic - Record of coplications: DKA, HONK, Hypos - Capillary blood glucose Fasting: 4.5-6.5mM 2h post prandial: 4.5-9mM
- HbA1C
Reflects exposure over last 6-8 weeks
Aim <45-50mM (7.5-8%)
BP, lipids
Complications - Macro Pulses, BP, cardiac auscultation - Micro Fundoscopy, ACR+U&Es, Sensory testing plus foot inspection
Competency
- With insulin injections
- Checking injection sites
- BM monitoring
Coping
- Psychosocial e.g depression
- Occupation
- Domestic
Lifestyle modifications for Diabetes Mellitus?
DELAYS - Diet Same as that considered healthy for everyone Decreased total calorie intake decreased refined CHO, increased complex CHO Increased soluble fibre decreased fat (especially saturated) decreased salt Avoid binge drinking
- Exercise
- Lipids
Risk of hyperlipidaemia
Primary prevention with statins if over >40 yrs - ABP
decreased Na intake and ETOH
Keep BP <130/80
ACEi best (B-B: mask hypos, thiazides: increased glucose) - Aspirin
Primary prevention if >50yrs or <50 with other CVD RFs.
Yearly/ 6-monthly check:
Smoking cessation
HTN - HbA1c checked every 3-6 months until stable, then 6 monthly. Target on lifestyle or with metformin = 48. Inclusion of a sulphonylurea = 53.
BP and Diabetes - No end organ damage: <140/80
End organ damage: <130/80
Management of diabetes - Oral hypoglycaemics - first line after lifestyle modification?
Aim HbA1c <6.5% / 48mmol
- Lifestyle Modification: delays
- Start Metformin (if HBA1c >target after lifestyle changes to reduce micro and macrovascular complications)
SE: Nausea, diarrhoea, abdo pain, lactic acidosis
CI: GFR<30, tissue hypoxia (sepsis, MI), morning before GA, iodinated contrast media, CKD (increase risk of lactic acidosis)
500mg after evening meal, increasing to 2g max.
Advise is to stop if patient is ill due to renal impairment.
If Metformin is contraindicated offer a DPP4 (gliptins), pioglitazone, sulfonylurea, SGLT-2 inhibitor)
Management of diabetes - Oral hypoglycaemics - after metformin?
If HbA1c >58 mmols (7.5%)
For non-obese patients
Metformin + Sulphonylureas (if HBA1c >target) such as gliclazide. Major hypoglycaemia concern with unpredictable eating/exercise habits).
OR
Metformin + SGLT2 inhibitor (empagliflozin) 10mg OD. (reduce CVS risk and renal benefits).
OR
Metformin + pioglitazone (contraindicated in patients with heart failure due to fluid retention).
OR
Metformin + DPP4 (gliptin) - sitagliptin (do not offer cardiovascular benefits, but few identified side effects). No weight gain, oral preparation. Therefore for obese patients.
What dual therapy do you use if metformin is not suitable?
- Gliptin plus pioglitazone (contraindicated if bladder cancer)
- Gliptin (DPP4 inhibitor) plus sulphonylurea (gliclizide)
- Pioglitazone + sulphonylurea
Gliptins = DPP4 = Inactivating GLP1 therefore block this to increase action of GLP1
Pioglitazone = PPAR - modifies transcription of insulin. Class is the Thiazolidinedione
Gliclazide = Sulphonylureas.
What is 3rd line treatment for diabetes mellitus
HBA1c >58
Triple therapy
- Metformin, gliptin and a sulphonylurea
- Metformin, pioglitazone (thiazolidinedione), sulphonylurea
- Metformin, pioglitazone or sulphonylurea and an SGLT-2 (pee out glucose)
Sensitise your body to insulin (metformin)
Starting insulin treatment - safe starting dose 0.1-0.3 U/kg
- Neutral Protamine Hagedorn (1-2 daily) + short-acting insulin
- Insulin determir or glargine alternative to NPH.
What if third-line is ineffective for DM?
- Consider Metformin, sulphonylurea and GLP-1 (exenatide) for those with BMI >35 or those with BMI <35 who would have occupational problems with insulin.
Exenatide leads to increased insulin secretion + inhibits glucagon secretions. Leads to weight loss. Within 60 mins before the morning and evening meals.
Consider adding exenatide to metformin and a sulfonylurea if:
BMI >= 35 kg/m² in people of European descent and there are problems associated with high weight, or
BMI < 35 kg/m² and insulin is unacceptable because of occupational implications or weight loss would benefit other comorbidities.
- Consider acarbose if unable to use other glucose-lowering drugs.